Cullen/Frost Bankers’s NeoGenomics NEO Stock Holding History

Cullen/Frost Bankers’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-495	Closed	-$6K	–	1151
2022 Q1	$6K	Hold	495	–	–	﹤0.01%	993
2021 Q4	$17K	Sell	495 -515	-51%	-$20.2K	﹤0.01%	907
2021 Q3	$49K	Hold	1,010	–	–	﹤0.01%	770
2021 Q2	$46K	Hold	1,010	–	–	﹤0.01%	799
2021 Q1	$49K	Hold	1,010	–	–	﹤0.01%	727
2020 Q4	$54K	Hold	1,010	–	–	﹤0.01%	697
2020 Q3	$37K	Hold	1,010	–	–	﹤0.01%	734
2020 Q2	$31K	Buy	+1,010	New	+$28K	﹤0.01%	738

Other funds holding NEO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Cullen/Frost Bankers's NEO Position: Q2 2022 in Review

Cullen/Frost Bankers sold out of NeoGenomics (NEO) in Q2 2022, closing a stake of 495 shares — an estimated $6K sold.

Cullen/Frost Bankers first reported a position in NEO in Q2 2020 and held it in 8 quarters. The position peaked at $54K in Q4 2020. 240 funds tracked by Wall St. Rank hold NEO as of Q2 2022.

Cullen/Frost Bankers reported no remaining NeoGenomics position as of Q2 2022 after selling out during the quarter.
Cullen/Frost Bankers sold 495 NeoGenomics shares in Q2 2022, an estimated $6K.
Cullen/Frost Bankers first reported a position in NeoGenomics in Q2 2020 and held it in 8 quarters.
Cullen/Frost Bankers's NeoGenomics position peaked at $54K in Q4 2020.
240 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2022.

Based on Cullen/Frost Bankers's 13F filing for Q2 2022, filed 5 Aug 2022.